It can be difficult to successfully navigate privacy laws such as HIPAA and remain compliant. Are you truly subject to HIPAA, or do you just believe that you are? Join regulatory attorney Darshan Kulkarni as he discusses a few of the most common...
As more states pass cannabis supportive laws, companies often need to reevaluate how they approach cannabis use. Are your employees using cannabis? Regulatory attorney Darshan Kulkarni discusses the legality of cannabis use at both the state and...
Are pharmaceutical companies allowed to provide financial assistance for travel, lodging and other expenses to certain patients? Join FDA regulatory attorney Darshan Kulkarni as he discusses why the Office of Inspector General (OIG) decided in favor...
Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
In the wake of COVID-19, many companies have had to reshape how they conduct business. What is the role of the general counsel during this time? How should general counsel officers determine the ways in which COVID-19 may impact their businesses...
What are the four branches of patient centricity, and how can they apply to your company? In this episode, Darshan Kulkarni explains how companies can foster patient centricity through privacy, transparency, innovation and access. Plus, how the FDA...